460 likes | 720 Views
MCB- Signal Transduction Lecture 1. General Concepts of Signal Transduction Cell Communication Types of Receptors Molecular Signaling Receptor Binding Scatchard Analysis Competitive Binding Second Messengers. Signaling throughout Evolution. Bacteria Sense nutrients
E N D
MCB- Signal Transduction Lecture 1 General Concepts of Signal Transduction Cell Communication Types of Receptors Molecular Signaling Receptor Binding Scatchard Analysis Competitive Binding Second Messengers
Signaling throughout Evolution • Bacteria • Sense nutrients • Lac operon--bacteria turn on gene expression of 3 genes necessary to metabolize lactose (Jacob & Monod, Nobel 1965) • Chemotaxis- che proteins that couple nutrient receptors to flagellar motors • Quorum sensing • Yeast • Pheromone signaling for haploid yeast mating • Multicellular Organisms Many signaling pathways (G proteins, channels, kinases)
The Integration of Biochemical Networks Pathogenic virus Growth factors Cell cycle and DNA repair Cell suicide (Apoptose) Cytokines
Can a biologist fix a radio? First step: obtain grants to purchase large number of functioning radios Perform comparative analysis: take out all the pieces, classify them and give them names Begin “genetic analysis” by bombarding functioning radio with small metal objects: misfunctioning radios will display “phenotypes” Lazebnik, Cancer Cell 2002
Can a biologist fix a radio? Lucky postdoc discovers Serendipitously Recovered Component (Src) that connects to the extendable object Most Important Component (Mic). Another lab identifies Really Important Component (Ric) in radios where Mic does not play important role. Undoubtedly-Mic (U-mic) controls Src & Ric (AM/FM switch)
Cell Communication Lodish, 20-1
Intracellular Receptors Ligands need to be lipophilic • Steroids • Thyroid hormone • Retinoids • Cell surface receptors Ligands can be either water soluble or lipophilic--but bind at the surface Lodish, 20-2
Four classes of cell-surface receptors Lodish, 20-3
Transmission of signals from one molecule to another 3 basic modes (may be combined) 1. Allostery Shape change, often induced by binding a protein or small molecule Switching can be very rapid 2. Covalent modification Modification itself changes molecule’s shape Memory device; may be reversible (or not) 3. Proximity(= regulated recruitment) Regulated molecule may already be in “signaling mode;” induced proximity to a target promotes transmission of the signal P P P
How quickly do you need your message to arrive? • VERY FAST (milliseconds) Nerve conduction, vision • Ion channels • FAST (seconds) Vision, metabolism, cardiovascular • G protein-coupled receptors • SLOW (minutes to hours) Cell division, proliferation, developmental processes • Growth factor receptors • Steroid hormones
General types of protein-protein interfaces A. Surface-string: examples include SH2 domains, kinase-substrate interactions B. Helix-helix: also called coiled-coil, found in several families of transcription factors C. Surface-surface: most common, often involve extended complementary surfaces, such as growth factor receptors. Alberts 5-34
Plasticity of Protein-protein interfaces Recent concept: Many hormones can bind to different receptors, and a single receptor can bind multiple different hormones. The common protein uses essentially the same contact residues to bind multiple partners. Example: The hinge region of Fc portion of IgG antibodies can bind to Staph A, Staph G, RF, and neonatal FcR. Co-crystallization of the hinge region with these four proteins reveals the plasticity of the interaction surface. Delano, et al. Science 2000
Specific binding of insulin to cells Receptor: ligand binding must be specific, saturable, and of high affinity Saturation Binding studies Can be performed in intact cells, membranes, or purified receptors 1. Add various amounts of labeled ligand (drug, hormone, growth factor) 2. To determine specific binding, add an excess of unlabeled ligand to compete for specific binding sites. QU: Why is there non-specific binding? 3. Bind until at equilibrium 4. Separate bound from unbound ligand 5. Count labeled ligand [Adapted from A. Ciechanover et al., 1983, Cell32:267.]
Reversibility & Timing Activity of a signaling machine often depends on its association with another molecule If the association is reversible, we can talk about . . . Equilibrium binding k1 k1 = association rate (A) + (B) (AB) k2 = dissociation rate k2 Forward reaction rate = (A)(B) k1 At equilibrium, the forward reaction goes at exactly the same rate as the backward reaction k2 Backward reaction rate = (AB) So . . . (A)(B) = (AB) k2 k1
k2 k2 k1 k1 Reversibility & Timing If . . . (A)(B) = (AB) k2 k1 Define So . . . dissociation constant (A)(B) Kd = = Kd = = (AB) Equilibrium binding is saturable 1.0 Bmax Kd = conc of A at which half of B binds A (AB) 0.5 Kd (A)
k2 k1 Reversibility & Timing Units (M-1)(sec-1) k1 = association rate constant Kd = k2 = dissociation rate constant (sec-1) k1 usually ~ 108M-1 sec-1 (diffusion-limited) k2 just a time constant (sec-1) Thus, knowing the Kd and assuming a “usual” rate of association, you can calculate . . . k2, and therefore the duration (or half-life*) of the (AB) complex *Half-life = 0.69 ÷ k2
Reversibility & Timing Half-life of (AB) k2 Kd LIGAND (M) (sec-1) (sec) Acetylcholine 10-6 102 0.007 Norepinephrine 100 0.7 10-8 Insulin 10-2 70 10 -10 *Half-life = 0.69 ÷ k2
Scatchard Analysis (Bound Lig) Slope = - 1/Kd (Free) X intercept = # rec (Bound Lig) For an excellent discussion of principles of receptor binding, and practical considerations, see http://www.graphpad.com; also posted on MCB website.
Scatchard Analysis Positive cooperativity: binding of ligand to first subunit increases Affinity of subsequent binding events. Example: hemoglobin binding O2 (Bound Lig) (Free) (Bound Lig) Negative cooperativity: binding of ligand to first subunit decreases affinity of subsequent binding events.
Cooperative binding The Hill equation accounts for the possibility that not all receptor sites are independent, and states that Fractional occupancy = Lfn/ (Kd + Lfn) n= slope of the Hill plot and also is the avg # of interacting sites For linear transformation, log [B/(Rt - B)] = n(log Lf) - log Kd If slope = 1, then single class of binding sites log [B/(Rt - B)] If slope > 1, then positive cooperativity Slope= n If slope < 1, then negative cooperativity log Lf
Competitive binding How many different types of ligands can a receptor bind? Are some ligands more avid for a receptor than others? You can use the ability of a compound (could be agonist or antagonist) to competitively displace the binding of a fixed amount of a different compound (usually a labeled antagonist). BIG ADVANTAGE: You only need one labeled compound. Example. Adrenergic agonists: isoproterenol (ISO), epinephrine (EPI) Adrenergic antagonists: phentolamine (PHEN) a-adrenergic receptor b-adrenergic receptor 100% 100% ISO PHEN PHEN ISO [competitor] [competitor]
So that’s the theory: How do we know whether or not it is true? 1. Theory is internally consistent(necessary, not sufficient for belief) 2. Binding experiments Stop binding reaction quickly, measure bound complex, (AB) Assess k1 = “on-rate” Assess k2 = “off-rate” Compare vs. Kd 3. Seeing is believing: Watch behavior of fluorescent-tagged single molecules of ligand bound to receptors
Seeing is believing* . . . Experimental system: Dictyostelium discoideum, a soil amoeba Question: Does GPCR signaling differ at front vs. back of the cell? Assess duration of ligand-GPCR complexes, during chemotaxis of living Dictyostelium cells
Seeing is believing, Total Internal Reflection Fluorescence Question: Does GPCR signaling differ at front vs. back of the cell? Approach: Tag cAMP ligand with a fluorescent dye Evanescent wave excites only tagged cAMP near slide Bound cAMP stays in one place on cell surface; unbound tagged cAMP diffuses rapidly away http://www.olympusmicro.com/primer/techniques/fluorescence/tirf/tirfintro.html
Each point is a separate cAMP/R complex Seeing is believing* . . . Off & On: cAMP-R complexes (movie: 7 sec total) Cell surface facing the slide cAMP-R complexes dissociate ~2.5 x faster at the front than at the back! Pseudopod k2 = 1.1 and 0.39 s-1 400 Tail Cy3-cAMP bound k2 = 0.39 and 0.16 s-1 True for cells in a ligand gradient and also in a uniform concentration of the ligand 0 0 5 10 15 20 25 Time (sec) *Ueda et al., Science 294:864,2001
Seeing is believing* . . . Each spot = 1 cAMP/R complex # spots per m2 of surface area equal at front and back of the cell (like receptor density) Spots move ~1-2 m/sec *Ueda et al., Science 294:864,2001
Seeing is believing* . . . Inferences Receptors at the front differ biochemically from those in the back Because receptor density and the # bound receptors are the same, faster dissociation (k2) at the front must be matched by faster association (k1) as well The functional difference is not created by the gradient, but instead reflects some difference between the front and back of the cell Questions What biochemical mechanism underlies this difference? (Probably reflects residence of the GPCRs and G proteins in different macromolecular complexes) *Ueda et al., Science 294:864,2001
Other methods of measuring binding • Surface plasmon resonance (BiaCore) Can measure “on” rates and “off” rates to calculate binding affinities • Isothermal calorimetry Very accurate, requires lots of protein and expensive equipment • Equilibrium dialysis Useful for binding of small ligands to large proteins • Fluorescence anisotropy Excite fluorescent protein with polarized light. Anisotropy refers to the extent that the emitted light is polarized--the larger the protein/complex, the slower the tumble rate and the greater the anisotropy • Co-immunoprecipitation • Yeast two-hybrid
Second messengers Molecular mediators of signal transduction. Cells carefully, and rapidly, regulate the intracellular concentrations. Second messengers can be used by multiple signaling networks (at the same time). • Cyclic nucleotides: cAMP, cGMP • Inositol phosphate (IP) • Diacylglycerol (DAG) • Calcium • Nitric oxide (NO) • Reactive oxygen species (ROS)
Earl Sutherland 1971 Nobel laureate Rall, et al. JBC 1956
Fischer & Krebs, Nobel 1992 Discovered that phosphorylase activity was regulated by the reversible step of phosphorylation. Identified PKA and some of the first phosphatases.
Positive cooperativity--binding of increases affinity for second cAMP cAMP regulates PKA activity PKA targets include Phosphorylase kinase and the transcription regulator, cAMP response element binding (CREB) protein Alberts 15-31,32
Diacylglycerol and Inositol Phosphates as second messengers Alberts, 15-35
Calcium acts as second (third?) messenger Lodish, 20-39
Calmodulin transduces cytosolic Ca2+ signal Calmodulin, found in all eukaryotic cells, and can be up to 1% of total mass. Upon activation by calcium, calmodulin can bind to multiple targets, such as membrane transport proteins, calcium pumps, CaM-kinases Alberts, 15-40
CaM-kinase II regulation Alberts, 15-41
Frequency of calcium oscillations influences a cell’s response CaM-kinase uses memory mechanism to decode frequency of calcium spikes. Requires the ability of the kinase to stay active after calcium drops. This is accomplished by autophosphorylation. Alberts 15-39,42 CaM-kinase II activity CaM-kinase II activity High frequency Ca2+ oscillations Low frequency Ca2+ oscillations
Calcium signaling also occurs in waves Calcium effects are local, because it diffuses much more slowly than does InsP3 InsP3 receptor is both stimulated and inhibited calcium Sperm binds Sensitivity of InsP3 R to Ca 2+ 0 sec 10 sec 20 sec 40 sec InsP3 [Ca 2+] Alberts, 15-37
NO signaling Gases can act as second messengers! NO effects are local, since it has half-life of 5-10 seconds (paracrine). NO activates guanylate cyclase by binding heme ring (allosteric mechanism) Lodish, 20-42
Discovery of NO signaling Furchgott, Ignarro, Murad, Nobel Prize 1998 Robert F Furchgott showed that acetylcholine-induced relaxation of blood vessels was dependent on the endothelium. His "sandwich" experiment set the stage for future scientific development. He used two different pieces of the aorta; one had the endothelial layer intact, in the other it had been removed. Louis Ignarro reported that EDRF relaxed blood vessels. He also identified EDRF as a molecule by using spectral analysis of hemoglobin. When hemoglobin was exposed to EDRF, maximum absorbance moved to a new wave-length; and exposed to NO, exactly the same shift in absorbance occurred! EDRF was identical with NO. http://www.nobel.se/medicine/laureates/1998/illpres/index.html
Reactive Oxygen Species (ROS) Signaling ROS important in cell’s adaptation to stress Many of longevity mutations map to ROS pathways Mutations in Superoxide Dismutase (SOD) cause amyotrophic lateral sclerosis (ALS, Lou Gehrig’s Disease) Unfortunately, no great clinical data showing that anti-oxidants will help us live longer! Finkel & Holbrook, Nature (2000)
ROS activates multiple pathways • Activation mechanisms ???? • Mimic ligand effect for GF receptors • Oxidants enhance phosphorylation of RTKs and augment ERK/Akt signaling • Inactivation of phosphatases • Hydrogen peroxide inactivates protein-Y phosphatase 1B • Redox sensors • Thioredoxin (Trx) binds and inhibits ASK1, an upstream activator of JNK/p38 pathways. ROS dissociates Trx-ASK1 complex HSF1, NF-kB, and ERK activities change with age (Pink boxes) Finkel & Holbrook, Nature (2000)